| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cell projection membrane | 1.69e-04 | 431 | 76 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | neuron projection membrane | 2.28e-04 | 82 | 76 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | cell leading edge | 4.59e-04 | 500 | 76 | 8 | GO:0031252 | |
| Domain | VCX/VCY1 | 1.26e-09 | 5 | 76 | 4 | IPR026653 | |
| Domain | VCX_VCY | 1.26e-09 | 5 | 76 | 4 | PF15231 | |
| Domain | WW | 1.31e-06 | 47 | 76 | 5 | PF00397 | |
| Domain | WW | 1.46e-06 | 48 | 76 | 5 | SM00456 | |
| Domain | WW_DOMAIN_2 | 1.98e-06 | 51 | 76 | 5 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.98e-06 | 51 | 76 | 5 | PS01159 | |
| Domain | WW_dom | 2.19e-06 | 52 | 76 | 5 | IPR001202 | |
| Domain | ETS_PEA3_N | 4.89e-05 | 3 | 76 | 2 | PF04621 | |
| Domain | ETS_PEA3_N | 4.89e-05 | 3 | 76 | 2 | IPR006715 | |
| Domain | ATP_Ca_trans_C | 9.75e-05 | 4 | 76 | 2 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 9.75e-05 | 4 | 76 | 2 | PF12424 | |
| Domain | P-type_ATPase_IIB | 9.75e-05 | 4 | 76 | 2 | IPR006408 | |
| Domain | Spectrin | 1.08e-04 | 23 | 76 | 3 | PF00435 | |
| Domain | Spectrin_repeat | 2.19e-04 | 29 | 76 | 3 | IPR002017 | |
| Domain | EF-hand_dom_typ1 | 2.43e-04 | 6 | 76 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 2.43e-04 | 6 | 76 | 2 | IPR015154 | |
| Domain | PAK_BD | 2.43e-04 | 6 | 76 | 2 | IPR033923 | |
| Domain | EF-hand_2 | 2.43e-04 | 6 | 76 | 2 | PF09068 | |
| Domain | EF-hand_3 | 2.43e-04 | 6 | 76 | 2 | PF09069 | |
| Domain | Spectrin/alpha-actinin | 2.95e-04 | 32 | 76 | 3 | IPR018159 | |
| Domain | - | 2.95e-04 | 32 | 76 | 3 | 3.40.1110.10 | |
| Domain | - | 2.95e-04 | 32 | 76 | 3 | 2.70.150.10 | |
| Domain | SPEC | 2.95e-04 | 32 | 76 | 3 | SM00150 | |
| Domain | ATPase_P-typ_cyto_domN | 3.86e-04 | 35 | 76 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 4.20e-04 | 36 | 76 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 4.20e-04 | 36 | 76 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 4.20e-04 | 36 | 76 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.55e-04 | 37 | 76 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.55e-04 | 37 | 76 | 3 | PF00122 | |
| Domain | TBC | 1.04e-03 | 49 | 76 | 3 | SM00164 | |
| Domain | - | 1.05e-03 | 12 | 76 | 2 | 3.90.810.10 | |
| Domain | RabGAP-TBC | 1.31e-03 | 53 | 76 | 3 | PF00566 | |
| Domain | TBC_RABGAP | 1.46e-03 | 55 | 76 | 3 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 1.46e-03 | 55 | 76 | 3 | IPR000195 | |
| Domain | FH2 | 1.66e-03 | 15 | 76 | 2 | PS51444 | |
| Domain | FH2_Formin | 1.66e-03 | 15 | 76 | 2 | IPR015425 | |
| Domain | FH2 | 1.66e-03 | 15 | 76 | 2 | PF02181 | |
| Domain | FH2 | 1.66e-03 | 15 | 76 | 2 | SM00498 | |
| Domain | GRAM | 1.89e-03 | 16 | 76 | 2 | SM00568 | |
| Domain | Post-SET_dom | 1.89e-03 | 16 | 76 | 2 | IPR003616 | |
| Domain | - | 1.89e-03 | 16 | 76 | 2 | 1.20.1110.10 | |
| Domain | PostSET | 1.89e-03 | 16 | 76 | 2 | SM00508 | |
| Domain | PBD | 1.89e-03 | 16 | 76 | 2 | SM00285 | |
| Domain | ATPase_P-typ_TM_dom | 1.89e-03 | 16 | 76 | 2 | IPR023298 | |
| Domain | POST_SET | 1.89e-03 | 16 | 76 | 2 | PS50868 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.14e-03 | 17 | 76 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.14e-03 | 17 | 76 | 2 | PF00689 | |
| Domain | PBD | 2.14e-03 | 17 | 76 | 2 | PF00786 | |
| Domain | ZZ | 2.40e-03 | 18 | 76 | 2 | PF00569 | |
| Domain | Cation_ATPase_N | 2.40e-03 | 18 | 76 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.40e-03 | 18 | 76 | 2 | SM00831 | |
| Domain | ZF_ZZ_2 | 2.40e-03 | 18 | 76 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.40e-03 | 18 | 76 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.67e-03 | 19 | 76 | 2 | IPR000433 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.67e-03 | 19 | 76 | 2 | IPR004014 | |
| Domain | ZnF_ZZ | 2.67e-03 | 19 | 76 | 2 | SM00291 | |
| Domain | CRIB | 2.96e-03 | 20 | 76 | 2 | PS50108 | |
| Domain | CRIB_dom | 3.26e-03 | 21 | 76 | 2 | IPR000095 | |
| Domain | GRAM | 3.58e-03 | 22 | 76 | 2 | PF02893 | |
| Domain | GRAM | 3.58e-03 | 22 | 76 | 2 | IPR004182 | |
| Domain | Actinin_actin-bd_CS | 3.91e-03 | 23 | 76 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 3.91e-03 | 23 | 76 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.91e-03 | 23 | 76 | 2 | PS00019 | |
| Domain | HAD-like_dom | 4.10e-03 | 79 | 76 | 3 | IPR023214 | |
| Domain | HECT | 5.37e-03 | 27 | 76 | 2 | PF00632 | |
| Domain | HECTc | 5.37e-03 | 27 | 76 | 2 | SM00119 | |
| Domain | HECT_dom | 5.37e-03 | 27 | 76 | 2 | IPR000569 | |
| Domain | HECT | 5.37e-03 | 27 | 76 | 2 | PS50237 | |
| Domain | ETS_DOMAIN_1 | 5.77e-03 | 28 | 76 | 2 | PS00345 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.07e-05 | 176 | 55 | 6 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 7.54e-05 | 183 | 55 | 6 | M997 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 1.91e-04 | 29 | 55 | 3 | M29808 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.34e-04 | 31 | 55 | 3 | MM1343 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.82e-04 | 33 | 55 | 3 | M6220 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.66e-04 | 36 | 55 | 3 | M39831 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 4.65e-04 | 39 | 55 | 3 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 5.01e-04 | 40 | 55 | 3 | M41816 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 9.62e-04 | 12 | 55 | 2 | M27326 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_SIGNALING | 9.62e-04 | 12 | 55 | 2 | M47841 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 9.62e-04 | 12 | 55 | 2 | M13618 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 9.62e-04 | 12 | 55 | 2 | MM14994 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 1.13e-03 | 13 | 55 | 2 | M6322 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.21e-03 | 54 | 55 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.21e-03 | 54 | 55 | 3 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.28e-03 | 55 | 55 | 3 | M971 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.32e-03 | 14 | 55 | 2 | MM15029 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.32e-03 | 14 | 55 | 2 | MM15052 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.42e-03 | 57 | 55 | 3 | MM15643 | |
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 10903929 | ||
| Pubmed | 1.23e-10 | 5 | 79 | 4 | 10607842 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 18076704 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EFNA5 NEDD4L LPP FRMPD1 ASPH APBB2 UBA6 PAK3 ATP9B FRYL ADGRV1 LARP4 UTRN ATP2B1 EVI5L MGRN1 | 1.98e-07 | 1489 | 79 | 16 | 28611215 |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 17342728 | ||
| Pubmed | NEDD4L HECW1 SSH1 SPTBN1 PAK1 NSD1 UBA6 PAK3 NOL9 GRM5 PRRC2A LRRFIP1 | 1.77e-06 | 963 | 79 | 12 | 28671696 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23622267 | ||
| Pubmed | The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3. | 5.09e-06 | 2 | 79 | 2 | 16738319 | |
| Pubmed | Modulation of neuritogenesis by a protein implicated in X-linked mental retardation. | 5.09e-06 | 2 | 79 | 2 | 19812318 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 30858169 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21115725 | ||
| Pubmed | The ability to induce microtubule acetylation is a general feature of formin proteins. | 5.09e-06 | 2 | 79 | 2 | 23110170 | |
| Pubmed | Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression. | 5.09e-06 | 2 | 79 | 2 | 27474226 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27909004 | ||
| Pubmed | PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion. | 5.09e-06 | 2 | 79 | 2 | 25766321 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24970476 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22815483 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12862317 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18827017 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26224636 | ||
| Pubmed | Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation. | 1.53e-05 | 3 | 79 | 2 | 10075701 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 15182717 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 23335370 | ||
| Pubmed | ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors. | 1.53e-05 | 3 | 79 | 2 | 22425584 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 12871699 | ||
| Pubmed | Group I Paks as therapeutic targets in NF2-deficient meningioma. | 1.53e-05 | 3 | 79 | 2 | 25596744 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 25203299 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 34948386 | ||
| Pubmed | The role of Pea3 group transcription factors in esophageal squamous cell carcinoma. | 1.53e-05 | 3 | 79 | 2 | 21689625 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 11578874 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 9878245 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 11509567 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 18507705 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 28161714 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 18492810 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 38785043 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22183401 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 30923534 | ||
| Pubmed | The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. | 1.53e-05 | 3 | 79 | 2 | 9823899 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 1827443 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 29860311 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 11786550 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 11278486 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 9285689 | ||
| Pubmed | 1.68e-05 | 22 | 79 | 3 | 27335464 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 20463033 | ||
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 3.05e-05 | 4 | 79 | 2 | 12209837 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 10852904 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 12784250 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 20062082 | ||
| Pubmed | PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. | 3.05e-05 | 4 | 79 | 2 | 9659915 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 12808150 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 15101689 | ||
| Pubmed | A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. | 3.05e-05 | 4 | 79 | 2 | 7493928 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 23413890 | ||
| Pubmed | PSD95beta regulates plasma membrane Ca2+ pump localization at the photoreceptor synapse. | 3.05e-05 | 4 | 79 | 2 | 19233278 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 19605360 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.05e-05 | 4 | 79 | 2 | 8245032 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 12578958 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 10577388 | ||
| Pubmed | β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1. | 3.05e-05 | 4 | 79 | 2 | 26627735 | |
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 3.05e-05 | 4 | 79 | 2 | 8634322 | |
| Pubmed | The KYxxL motif in Rad17 protein is essential for the interaction with the 9-1-1 complex. | 3.05e-05 | 4 | 79 | 2 | 27387238 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.05e-05 | 4 | 79 | 2 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 3.05e-05 | 4 | 79 | 2 | 11152753 | |
| Pubmed | Ret and Etv4 Promote Directed Movements of Progenitor Cells during Renal Branching Morphogenesis. | 3.05e-05 | 4 | 79 | 2 | 26894589 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 10461188 | ||
| Pubmed | A brain serine/threonine protein kinase activated by Cdc42 and Rac1. | 3.05e-05 | 4 | 79 | 2 | 8107774 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 28408625 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 24089499 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 15138262 | ||
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 3.05e-05 | 4 | 79 | 2 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 3.05e-05 | 4 | 79 | 2 | 10434059 | |
| Pubmed | CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. | 3.05e-05 | 4 | 79 | 2 | 19819308 | |
| Pubmed | FMN1 SPTBN1 LPP FRMPD1 NSD1 FMN2 FRYL NOL9 UTRN ATP2B1 RAD17 | 3.34e-05 | 1084 | 79 | 11 | 11544199 | |
| Pubmed | 3.55e-05 | 28 | 79 | 3 | 27578777 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLEKHG1 SETD1A TBC1D9B SSH1 PKD1 NSD1 SLC10A3 FRYL AP3D1 TBC1D9 EVI5L | 3.97e-05 | 1105 | 79 | 11 | 35748872 |
| Pubmed | 4.55e-05 | 568 | 79 | 8 | 9110174 | ||
| Pubmed | A "double adaptor" method for improved shotgun library construction. | 4.89e-05 | 574 | 79 | 8 | 8619474 | |
| Pubmed | Structure and functional implications of the human rad9-hus1-rad1 cell cycle checkpoint complex. | 5.07e-05 | 5 | 79 | 2 | 19535328 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 27783944 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 17938178 | ||
| Pubmed | Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. | 5.07e-05 | 5 | 79 | 2 | 23509247 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 15485898 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 11430802 | ||
| Pubmed | The human checkpoint protein hRad17 interacts with the PCNA-like proteins hRad1, hHus1, and hRad9. | 5.07e-05 | 5 | 79 | 2 | 10884395 | |
| Pubmed | 5.43e-05 | 90 | 79 | 4 | 15033168 | ||
| Pubmed | Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization. | 6.42e-05 | 34 | 79 | 3 | 23533177 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 12763866 | ||
| Pubmed | Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. | 7.60e-05 | 6 | 79 | 2 | 10205168 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 12237306 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 33482876 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 21097508 | ||
| Pubmed | Pak1 is involved in dendrite initiation as a downstream effector of Rac1 in cortical neurons. | 7.60e-05 | 6 | 79 | 2 | 12213441 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 26632490 | ||
| Pubmed | Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse. | 7.60e-05 | 6 | 79 | 2 | 9245586 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 14624239 | ||
| Pubmed | Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth. | 7.60e-05 | 6 | 79 | 2 | 22764250 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 15466854 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 22340503 | ||
| Cytoband | 5q13 | 6.60e-04 | 22 | 79 | 2 | 5q13 | |
| Cytoband | Xp22 | 8.55e-04 | 25 | 79 | 2 | Xp22 | |
| Cytoband | 4q31.21 | 9.25e-04 | 26 | 79 | 2 | 4q31.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 9.36e-04 | 250 | 79 | 4 | chrXp22 | |
| Cytoband | 3q28 | 1.23e-03 | 30 | 79 | 2 | 3q28 | |
| GeneFamily | Variable charge X/Y family | 1.29e-12 | 6 | 55 | 5 | 368 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.77e-04 | 36 | 55 | 3 | 823 | |
| GeneFamily | ATPases Ca2+ transporting | 3.23e-04 | 9 | 55 | 2 | 1209 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 6.94e-04 | 13 | 55 | 2 | 1146 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.35e-03 | 18 | 55 | 2 | 91 | |
| GeneFamily | ETS transcription factor family | 3.26e-03 | 28 | 55 | 2 | 534 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.79e-03 | 34 | 55 | 2 | 487 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP | 2.07e-05 | 517 | 77 | 9 | M7140 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_UP | 2.40e-05 | 195 | 77 | 6 | M5593 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 3.45e-05 | 208 | 77 | 6 | M39233 | |
| Coexpression | EPPERT_HSC_R | 3.69e-05 | 127 | 77 | 5 | M19231 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | NRSN2 DRP2 NEDD4L ETV4 PAK3 FMN2 NCKAP5 FRYL ZDBF2 ADGRV1 C8orf34 ATP2B2 LIN28A INPP4B RUFY3 | 1.80e-06 | 986 | 76 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 6.53e-05 | 493 | 76 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 6.85e-05 | 496 | 76 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-09 | 198 | 77 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-09 | 198 | 77 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-08 | 195 | 77 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.33e-08 | 198 | 77 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.33e-08 | 198 | 77 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-08 | 198 | 77 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 5.06e-07 | 170 | 77 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 7.07e-07 | 180 | 77 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-06 | 193 | 77 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-06 | 193 | 77 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-06 | 196 | 77 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 196 | 77 | 6 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-06 | 198 | 77 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-06 | 198 | 77 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.33e-06 | 159 | 77 | 5 | b1d5ebd0c186b6d0279dab20d8f3b4a915acdc1f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 160 | 77 | 5 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 160 | 77 | 5 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 179 | 77 | 5 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 184 | 77 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 184 | 77 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.73e-05 | 185 | 77 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.73e-05 | 185 | 77 | 5 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.82e-05 | 187 | 77 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.87e-05 | 188 | 77 | 5 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.87e-05 | 188 | 77 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.97e-05 | 190 | 77 | 5 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-05 | 191 | 77 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-05 | 191 | 77 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-05 | 191 | 77 | 5 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 191 | 77 | 5 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.07e-05 | 192 | 77 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.07e-05 | 192 | 77 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-05 | 193 | 77 | 5 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 77 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.23e-05 | 195 | 77 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 195 | 77 | 5 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.23e-05 | 195 | 77 | 5 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.23e-05 | 195 | 77 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-05 | 196 | 77 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-05 | 196 | 77 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.28e-05 | 196 | 77 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.28e-05 | 196 | 77 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.28e-05 | 196 | 77 | 5 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 77 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-05 | 197 | 77 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-05 | 198 | 77 | 5 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-05 | 198 | 77 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-05 | 199 | 77 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-05 | 199 | 77 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-05 | 199 | 77 | 5 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.52e-05 | 200 | 77 | 5 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.52e-05 | 200 | 77 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 144 | 77 | 4 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-04 | 155 | 77 | 4 | ab539c04f10276ae919d82b1c75f99a84eb695bf | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-04 | 155 | 77 | 4 | 9a27558c457f05808af07190b7a5006b047f1d58 | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.66e-04 | 159 | 77 | 4 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 160 | 77 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 160 | 77 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.87e-04 | 164 | 77 | 4 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | C_02|World / shred on cell type and cluster | 1.92e-04 | 165 | 77 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 165 | 77 | 4 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 165 | 77 | 4 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-04 | 166 | 77 | 4 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.05e-04 | 168 | 77 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.05e-04 | 168 | 77 | 4 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 2.15e-04 | 170 | 77 | 4 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.15e-04 | 170 | 77 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.25e-04 | 172 | 77 | 4 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 173 | 77 | 4 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 69 | 77 | 3 | 3074ec10315fb21048215125ec08b0d7922da3d9 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 69 | 77 | 3 | f731d4500b139a8bef5c9185368509bf5a3791db | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 69 | 77 | 3 | 40eb84fe36da5a4a82bd9b2d962b829e2c97a059 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.35e-04 | 174 | 77 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 175 | 77 | 4 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-04 | 176 | 77 | 4 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 178 | 77 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.61e-04 | 179 | 77 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 179 | 77 | 4 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.61e-04 | 179 | 77 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-04 | 180 | 77 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.67e-04 | 180 | 77 | 4 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.67e-04 | 180 | 77 | 4 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 2.67e-04 | 180 | 77 | 4 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 180 | 77 | 4 | 3d54cc767e25d91ed2203d8a03e5bf5e15f21699 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.73e-04 | 181 | 77 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 181 | 77 | 4 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | E18.5-samps|World / Age Group, Lineage, Cell class and subclass | 2.78e-04 | 182 | 77 | 4 | 9649f15858d1ede73e068afc59df3ac367b49687 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.78e-04 | 182 | 77 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 182 | 77 | 4 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 182 | 77 | 4 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-04 | 182 | 77 | 4 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 182 | 77 | 4 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 182 | 77 | 4 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 182 | 77 | 4 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 182 | 77 | 4 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 182 | 77 | 4 | 6f5228ac47f9ab46d165740cf2655b5ba217acbe | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 2.84e-04 | 183 | 77 | 4 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 4.55e-06 | 196 | 77 | 7 | 5323_UP | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 4.70e-06 | 197 | 77 | 7 | 335_DN | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 5021_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 5288_UP | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; HL60; HG-U133A | 5.38e-05 | 196 | 77 | 6 | 1781_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 4834_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 2667_DN | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; HL60; HG-U133A | 5.38e-05 | 196 | 77 | 6 | 1990_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 3256_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 1536_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 5232_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 2128_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 6952_UP | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; HL60; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 2992_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; HL60; HG-U133A | 5.53e-05 | 197 | 77 | 6 | 1602_DN | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 3722_DN | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; HL60; HG-U133A | 5.69e-05 | 198 | 77 | 6 | 1611_UP | |
| Drug | C75; Up 200; 10uM; PC3; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 6428_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 5213_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 6332_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A | 5.85e-05 | 199 | 77 | 6 | 346_DN | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; HL60; HG-U133A | 5.85e-05 | 199 | 77 | 6 | 1989_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; HL60; HG-U133A | 5.85e-05 | 199 | 77 | 6 | 2024_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.85e-05 | 199 | 77 | 6 | 7279_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 5.85e-05 | 199 | 77 | 6 | 3128_DN | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 5.85e-05 | 199 | 77 | 6 | 596_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 6.02e-05 | 200 | 77 | 6 | 5355_DN | |
| Drug | lanthanum chloride hydrate | 6.27e-05 | 23 | 77 | 3 | CID000165791 | |
| Drug | DB07586 | 1.16e-04 | 74 | 77 | 4 | CID005287979 | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 3.71e-05 | 4 | 74 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 9.25e-05 | 6 | 74 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | bipolar disorder (implicated_via_orthology) | 1.29e-04 | 7 | 74 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | volumetric bone mineral density | 1.62e-04 | 42 | 74 | 3 | EFO_0007620 | |
| Disease | Malignant neoplasm of breast | ABCC1 KIF6 TBC1D9B FRMPD1 PAK1 ETV4 PRRC2A INPP4B LRRFIP1 METTL6 | 3.40e-04 | 1074 | 74 | 10 | C0006142 |
| Disease | polychlorinated biphenyls measurement, gestational serum measurement | 4.03e-04 | 12 | 74 | 2 | EFO_0007042, EFO_0007964 | |
| Disease | cortical surface area measurement | PLEKHG1 KIF6 EFNA5 SPTBN1 PKD1 NCKAP5 FRYL ADGRV1 QARS1 PRRC2A LIN28A | 5.06e-04 | 1345 | 74 | 11 | EFO_0010736 |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.25e-03 | 84 | 74 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 1.26e-03 | 21 | 74 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | urate measurement | 1.79e-03 | 895 | 74 | 8 | EFO_0004531 | |
| Disease | lobe attachment | 1.84e-03 | 207 | 74 | 4 | EFO_0007667 | |
| Disease | aspartate aminotransferase measurement | 1.90e-03 | 904 | 74 | 8 | EFO_0004736 | |
| Disease | hypertension, COVID-19 | 2.09e-03 | 27 | 74 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | Bilateral Wilms Tumor | 2.41e-03 | 29 | 74 | 2 | C2930471 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 2.41e-03 | 29 | 74 | 2 | DOID:11984 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLDEDSLPSSDEELL | 726 | Q96CN4 | |
| PRTPSLHDSDNDELS | 531 | Q9H2F5 | |
| LRNAPHPDDDDSCSI | 396 | Q92870 | |
| SPESHSPRDLDSEVF | 166 | Q8NC06 | |
| EAHAEVSILPDDLPE | 3851 | Q8WXG9 | |
| EERTEESLPILHSPD | 421 | Q49A92 | |
| HESSPLDLASEEPER | 136 | Q9NWX5 | |
| PDSSEPVVEDERLHH | 236 | Q12797 | |
| SDELSEPEHEAARPV | 311 | Q5BKX8 | |
| RIEDSEPHIPLIDDT | 1151 | P20020 | |
| EDSQPHIPLIDDTDL | 1176 | Q01814 | |
| SRHPATVEGEEPEDT | 91 | Q8IXJ9 | |
| RHSSLPTESDEDIAP | 756 | O14617 | |
| RPVSEEDTVPLSHLD | 446 | P43268 | |
| DEFPEHRTPSASILE | 1201 | Q96L73 | |
| LTELDSPRLPSHLSE | 411 | O75943 | |
| ESDIISLSQEPDEHP | 56 | Q68DA7 | |
| ESEPELESASSCHRP | 96 | Q5SY16 | |
| ERPEISLPSDFEHTI | 66 | O75914 | |
| DDDVPSLHSEPVARS | 1036 | P41594 | |
| SPDPNPDSSEVLDRH | 31 | A0A1B0GTS1 | |
| IHPDDEEISLSTEPE | 346 | Q76N89 | |
| FTREDSDPPIHESLS | 316 | O43861 | |
| EPSLTDAIPSHPRED | 561 | O15327 | |
| RSPSSPIHEEDEEKL | 456 | O60291 | |
| HRPLDLDTPTSEESS | 1531 | Q2LD37 | |
| DDLPSHEAPLADSLE | 806 | Q99665 | |
| DAHEAPPTLIEERRD | 151 | P09131 | |
| IDHDLDFSPESPARV | 231 | P11678 | |
| DSATDETIPDHPDLL | 2511 | O94915 | |
| ETIPDHPDLLLQSED | 2516 | O94915 | |
| LDELHSDLDLSRVPD | 286 | Q9Y239 | |
| LLDPRHEASSLEDLP | 156 | Q6ZMV9 | |
| SSVAPSFRPEDELEH | 381 | Q93052 | |
| SEEDTLPLTHFEDSP | 476 | P41161 | |
| TKAEPLDPEADSHVE | 146 | Q9GZP1 | |
| EEDTHPVVPDLRESS | 666 | Q9Y5F7 | |
| SPDPNPDSSEVLDRH | 31 | A0A1B0GWH4 | |
| DECRAHDPSVRPSVD | 446 | Q8NB16 | |
| DLTKDDLLDHVPPES | 136 | Q8TCB7 | |
| ERPEISLPSDFEHTI | 71 | Q13153 | |
| LHPPLAFEDGSSDEE | 756 | Q5SYB0 | |
| EDDRISRPHPSTAES | 456 | Q71RC2 | |
| EPADDTVHESAEPSR | 186 | P52803 | |
| LDPDTAHPELFLSED | 331 | Q8WVV5 | |
| PPDEEHRLEDAETES | 631 | Q9NZ56 | |
| TSLGRPEEEEDELAH | 111 | P36551 | |
| DLRASHPEDPASVVE | 446 | Q9UHL4 | |
| EELEEPHSESKDTSP | 176 | Q13474 | |
| EDADRCTLPEHESPS | 721 | Q32MZ4 | |
| RLHPDEDDTLVESPA | 3621 | P98161 | |
| TFEHLRSDPEPSIRE | 1286 | Q6ZUA9 | |
| SHEELEPDSIERRPV | 621 | P33527 | |
| SLSRHSSPTEERDEP | 1246 | Q9Y6R4 | |
| DDISLTPDPEPTHED | 46 | Q7L099 | |
| SHPLDPIDTVDFERE | 96 | P47897 | |
| STAPEEEHESPRAET | 286 | P46939 | |
| PETETHERETELFSP | 61 | Q32P41 | |
| HERETELFSPPSDVR | 66 | Q32P41 | |
| HDPLSQESELEEPLS | 101 | Q9NNX9 | |
| HDPLSQESELEEPLS | 101 | Q9H321 | |
| HDPLSQESELEEPLS | 101 | O14598 | |
| IESSDSGEPPTRDEH | 901 | O14513 | |
| PPDHRQEASADLPSE | 436 | Q5T2S8 | |
| PPLASESTHEDRNVE | 211 | O60921 | |
| ETHESDLAPSDKEAP | 1111 | P48634 | |
| PLSELEKEAHESTPE | 571 | Q2M3M2 | |
| EKEAHESTPEISERP | 576 | Q2M3M2 | |
| ETTPSLHSEDPRLQD | 286 | Q6P1J6 | |
| ETSDEAERPRPLLSH | 1281 | O15047 | |
| LDPEDISVDHPDEKS | 251 | Q01082 | |
| SPEDETGSLVHLEDP | 521 | Q8WYL5 | |
| HLRALLSSSDDPPAE | 746 | Q66K14 | |
| LSPDEEADTGSLHDP | 201 | Q8IXP5 | |
| PDHVPISSEDERNAI | 811 | A0AVT1 | |
| HDPLSQESEVEEPLS | 101 | Q9H322 | |
| EPLPASLAPDSEEHS | 1111 | Q6ZT07 | |
| RPSEVSEPIEELHSR | 106 | Q9HCK1 | |
| HDPLSQEAELEEPLS | 101 | Q9H320 | |
| DDVPDRLHAESTPEL | 866 | Q9ULL1 | |
| PARDPETDKHTEDQS | 6 | Q6ZMS7 | |
| FREEEEEIHSPTLLP | 191 | Q9H9Z2 | |
| REPHLASSPRDEDLV | 66 | Q9UQQ1 | |
| SRRHISEDLEPEPSE | 251 | Q96PU5 |